10 March 2026 in GYNECOLOGY
Functional hypothalamic amenorrhea (FHA) is a condition that occurs as a result of a malfunction of the hypothalamic-pituitary-ovarian axis in women of reproductive age due to effects of environmental factors, many of which are widely known. However, the factors that determine the individual predisposition to this condition, as well as the duration and severity of its course, remain unexplored. Epigenetic modifications that alter gene activity without altering DNA structure are among the most promising markers of many diseases, including those involving the hypothalamus-pituitary system. The pathogenetic role of one of the key epigenetic regulators in the genesis of these diseases – non-coding RNAs – is actively being studied. Also, the potential of using non-coding RNAs as therapeutic agents in some conditions is being investigated. The purpose of the review was to systematize the literature data on the potential role of microRNAs as one of the most actively studied epigenetic regulators in the pathogenesis of FHA. The main types of epigenetic modifications and current data on their role in the development of diseases involving the hypothalamus-pituitary system, as well as conditions associated with FHA, are described. The study of epigenetic regulators whose activity is altered by external factors in FHA development is highly promising. Moreover, further studies are needed to evaluate the potential of epigenetic regulators as therapeutic agents in patients with FHA to improve treatment effectiveness and minimize the adverse consequences of the disease on reproductive and somatic health.